CRF Health, a global provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences industry based in Plymouth Meeting, Pa., has announced a new partnership with Vodafone, a British multinational telecommunications company. CRF Health will use Vodafone’s global Machine-to-Machine (M2M) platform to offer an enhanced service to clinical trial operators and their patients.

As a result of the partnership, managing mobile data sending in clinical studies using the TrialMax eCOA platform will be significantly easier and more predictable for CRF Health clients. The agreement provides clinical trial sponsors running global studies with assured connectivity and instant access to data through Vodafone’s global network. Reliability, security and integration are crucial to ensure that healthcare industry requirements and standards are met.

“Having a trusted communications services partner is critical for us," said Jaime Racine, CRF Health’s vice president of contracts and vendor management. "Partnering with Vodafone will help us provide our clients with more predictable data sending, while improving the quality of our products and services.”

Cyril Deschanel, Vodafone Group’s head of M2M sales for Northern Europe, said, “Our global M2M platform and services allow CRF Health to confidently provide customers with reliable, global end-to-end solutions for clinical trials to ensure the highest quality outcomes. Working together with CRF Health, we can achieve their goal of a seamless global experience and greater operational efficiency.”